SATB1 gene expression and breast cancer prognosis

Breast

Volumn 20, Issue 4, 2011, Pages 309-313

  Hanker, Lars C ^a   Karn, Thomas ^a   Mavrova Risteska, Loreta ^a   Ruckhäberle, Eugen ^a   Gaetje, Regine ^a   Holtrich, Uwe ^a   Kaufmann, Manfred ^a   Rody, Achim ^a   Wiegratz, Inka ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Breast cancer prognosis; Estrogen receptor; Genome organizer; Microarray

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA MICROARRAY; GENE EXPRESSION; GENE TARGETING; GENETIC MARKER; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; ONCOGENE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 1 GENE; TUMOR VOLUME;

EID: 79960570808     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2010.10.002     Document Type: Article

References (29)

1. Nakayama Y., Mian I.S., Kohwi-Shigematsu T., Ogawa T. A nuclear targeting determinant for SATB1, a genome organizer in the T cell lineage. Cell Cycle 2005 Aug, 4(8):1099-1106.
2. Cai S., Han H.J., Kohwi-Shigematsu T. Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 2003 May, 34(1):42-51.
3. Wen J., Huang S., Rogers H., Dickinson L.A., Kohwi-Shigematsu T., Noguchi C.T. SATB1 family protein expressed during early erythroid differentiation modifies globin gene expression. Blood 2005 Apr 15, 105(8):3330-3339.
4. Alvarez J.D., Yasui D.H., Niida H., Joh T., Loh D.Y., Kohwi-Shigematsu T. The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev 2000 Mar 1, 14(5):521-535.
5. Han H.J., Russo J., Kohwi Y., Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008 Mar 13, 452(7184):187-193.
6. Patani N., Jiang W., Mansel R., Newbold R., Mokbel K. The mRNA expression of SATB1 and SATB2 in human breast cancer. Cancer Cell Int 2009 Jul 30, 9:18.
7. Rody A., Karn T., Ruckhäberle E., Müller V., Gehrmann M., Solbach C., et al. Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer. Breast Cancer Res Treat 2009 Feb, 113(3):457-466.
8. Rody A., Holtrich U., Gaetje R., Gehrmann M., Engels K., von Minckwitz G., et al. Poor outcome in estrogen receptor-positive breast cancers predicted by loss of Plexin B1. Clin Cancer Res 2007 Feb 15, 13(4):1115-1122.
9. Ruckhäberle E., Rody A., Engels K., Gaetje R., von Minckwitz G., Schiffmann S., et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat 2008 Nov, 112(1):41-52.
10. Wirapati P., Sotiriou C., Kunkel S., Farmer P., Pradervand S., Haibe-Kains B., et al. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 2008, 10(4):R65.
11. Desmedt C., Haibe-Kains B., Wirapati P., Buyse M., Larsimont D., Bontempi G., et al. Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res 2008 Aug 15, 14(16):5158-5165.
12. Ein-Dor L., Kela I., Getz G., Givol D., Domany E. Outcome signature genes in breast cancer: is there a unique set?. Bioinformatics 2005 Jan 15, 21(2):171-178.
13. Ahr A., Karn T., Solbach C., Seiter T., Strebhardt K., Holtrich U., et al. Identification of high risk breast cancer patients by gene expression profiling. Lancet 2002 Jan 12, 359(9301):131-132.
14. Rody A., Karn T., Solbach C., Gaetje R., Munnes M., Kissler S., et al. The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial. Breast 2007 Jun, 16(3):235-240.
15. Pawitan Y., Bjohle J., Amler L., Borg A.L., Egyhazi S., Hall P., et al. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population based cohorts. Breast Cancer Res 2005, 7(6):R953-R964.
16. Miller L.D., Smeds J., George J., Vega V.B., Vergara L., Ploner A., et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 2005 Sep 20, 102(38):13550-13555.
17. Wang Y., Klijn J.G., Zhang Y., Sieuwerts A.M., Look M.P., Yang F., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005 Feb 19-25, 365(9460):671-679.
18. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., et al. Genes that mediate breast cancer metastasis to lung. Nature 2005 Jul 28, 436(7050):518-524.
19. Sotiriou C., Wirapati P., Loi S., Harris A., Fox S., Smeds J., et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006 Feb 15, 98(4):262-272.
20. Hess K.R., Anderson K., Symmans W.F., Valero V., Ibrahim N., Mejia J.A., et al. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol 2006 Sep 10, 24(26):4236-4244.
21. Loi S., Haibe-Kains B., Desmedt C., Lallemand F., Tutt A.M., Gillet C., et al. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 2007 Apr 1, 25(10):1239-1246.
22. Desmedt C., Piette F., Loi S., Wang Y., Lallemand F., Haibe-Kains B., et al. TRANSBIG consortium: strong time dependence of the 76-gene prognostic signature for nodenegative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 2007 Jun 1, 13(11):3207-3214.
23. The expO project (expression project for Oncology) http://www.intgen.org/.
24. Karn T., Metzler D., Ruckhäberle E., Hanker L., Gätje R., Solbach C., et al. Data driven derivation of cutoffs from a pool of 3030 affymetrix arrays to stratify distinct clinical types of breast cancer. Breast Cancer Res Treat 2010 Apr, 120(3):567-579.
25. Affymetrix. Statistical algorithms reference guide, Technical report, Affymetrix; 2001.
26. Gautier L., Cope L., Bolstad B.M., Irizarry R.A. affy - analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004 Feb 12, 20(3):307-315.
27. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5(10):R80.
28. Eklund A.C., Szallasi Z. Correction of technical bias in clinical microarray data improves concordance with known biological information. Genome Biol 2008, 9(2):R26.
29. Iorns E., Hnatyszyn H.J., Seo P., Clarke J., Ward T., Lippman M. The role of SATB1 in breast cancer pathogenesis. J Natl Cancer Inst 2010 Aug 18, 102(16):1284-1296.